In vitro rapid diagnostic test for the detection of OXA-23, OXA-40/58 and NDM carbapenemases in bacterial culture.
The development of the kit was performed in collaboration with DZIF (Deutschen Zentrum für Infektionsforschung - German Center for Infection Research) and IMMIH (Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Uniklinik Köln - the Institute for Medical Microbiology, Immunology and Hygiene, University Hospital Cologne)
Advantage
1 unique kit to detect 4 clinically-relevant carbapenemases
No equipment required
Easy and ready to use
Shortest Time-To-Result
Adopted by many laboratories and references centers
Detection of asymptomatic carriers
Better management of medical decision strategies
Facilitates the quarantine of patients and conversely the lifting of the isolation of these patients
Anticipation of treatment if infection has occurred